Insider Transactions in Q4 2023 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 14
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,376
-1.88%
|
$28,512
$12.02 P/Share
|
|
Dec 12
2023
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
978
-0.58%
|
$9,780
$10.55 P/Share
|
|
Dec 11
2023
|
Jonathan Mc Neill Chief Business Officer |
SELL
Open market or private sale
|
Direct |
1,245
-0.79%
|
$12,450
$10.72 P/Share
|
|
Dec 11
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,380
-1.08%
|
$13,800
$10.72 P/Share
|
|
Dec 11
2023
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,467
-0.82%
|
$14,670
$10.72 P/Share
|
|
Dec 11
2023
|
Joshua T Brumm CEO & President |
SELL
Open market or private sale
|
Direct |
7,585
-1.28%
|
$75,850
$10.72 P/Share
|
|
Dec 11
2023
|
Wildon Farwell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,688
-0.98%
|
$16,880
$10.72 P/Share
|
|
Dec 11
2023
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,616
-0.85%
|
$16,160
$10.72 P/Share
|
|
Dec 06
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,872
-1.44%
|
$22,464
$12.01 P/Share
|
|
Dec 04
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
681
-0.52%
|
$8,172
$12.01 P/Share
|
|
Nov 15
2023
|
Jonathan Mc Neill Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96,158
+38.02%
|
-
|
|
Nov 15
2023
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Grant, award, or other acquisition
|
Direct |
89,742
+40.74%
|
-
|
|
Nov 15
2023
|
Wildon Farwell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
82,512
+32.45%
|
-
|
|
Nov 15
2023
|
Susanna Gatti High Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
94,893
+33.37%
|
-
|
|
Nov 15
2023
|
Joshua T Brumm CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
358,877
+37.72%
|
-
|
|
Nov 15
2023
|
Oxana Beskrovnaya Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
93,718
+34.48%
|
-
|
|
Nov 02
2023
|
Susanna Gatti High Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
9,939
-9.51%
|
$69,573
$7.4 P/Share
|